Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-17

Clinical Trial Update: Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the long-term effects of tiotropium (Spiriva) on lung function in chronic obstructive pulmonary disease patients has completed and po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2009-08-17